Wanling L. is a seasoned professional in the healthcare and pharmaceutical sectors, currently serving as Senior Manager of US Analytics for Hematology at Amgen since November 2021. Prior roles include Oncology Commercial Insights Manager at Amgen, International Marketing Product Manager at Medtronic, and Business Intern at Meditope Biosciences, where Wanling analyzed the antibody drug conjugates market. Notable achievements include leading a cross-functional team at Johnson & Johnson to launch ERLEADA® and driving significant sales growth for TAXOTERE® at Sanofi. Wanling holds an MBA in Healthcare Management & Marketing Analytics from UCLA Anderson School of Management and a Bachelor of Pharmacy from Taipei Medical University.
This person is not in the org chart
This person is not in any teams
Amgen
252 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.